86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03782818 (ClinicalTrials.gov)	November 20, 2019	17/12/2018	Olaparib for PAH: a Multicenter Clinical Trial	Olaparib for Pulmonary Arterial Hypertension: a Multicenter Clinical Trial	Pulmonary Arterial Hypertension	Drug: Olaparib	Laval University	Canadian Institutes of Health Research (CIHR);AstraZeneca	Recruiting	18 Years	75 Years	All	20	Phase 1/Phase 2	Canada
2	NCT03251872 (ClinicalTrials.gov)	October 25, 2018	13/8/2017	Olaparib for PAH: a Pilot Study	Olaparib for Pulmonary Arterial Hypertension: a Pilot Clinical Study	Pulmonary Arterial Hypertension	Drug: Olaparib	Laval University	NULL	Terminated	18 Years	75 Years	All	6	Early Phase 1	Canada

First Previous1Next Last